NEA Approved Features

Atopic dermatitis is a chronic disease requiring long-term monitoring of symptoms and triggers. Patients can proactively monitor their eczema with a new, easy-to-use mobile app.

Dr Alexis shares how he creates care plans for his patients with atopic dermatitis and shares insights on the current and future therapies.

As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.

New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.

Patients often describe seeking alternatives and adjuncts to care for the treatment of their atopic dermatitis. The literature has explored some of the potential in these options.

While much of research is to test the clinical efficacy and safety of drugs, these posters from the American Academy of Dermatology Virtual Meeting Experience 2020 focused on physician decision-making and evaluation, patient characteristics, and disease severity of eczema.

Atopic dermatitis can have a significant effect on the quality of life of all patients, especially for the children and adolescents who are primarily affected by the disease.

The Centers for Disease Control and Prevention and World Health Organization advise that hand washing is critical to slowing the spread of infection, but patients with dermatitis may need further guidance from their dermatologists.

A murine model showed success in treating atopic dermatitis by activating natural killer cells instead of suppressing the immune response. The Dermatologist spoke with researcher Brian S. Kim, MD, about the future of this immunotherapeutic strategy.

Patients with eczema often wonder if their diet can affect their disease severity. In an interview with The Dermatologist, Aaron Drucker, MD, discussed his study on the role of gluten as a risk factor for inflammatory disease severity.